Nebenwirkungen · Sycrest
Sycrest 5 mg sublingual tablets · Abschnitt 4.8 · PDF-Seite 6
HOS-212340 · Präparat HOS-154872
Tabulated list of adverse reactions The incidences of the ADRs associated with asenapine therapy are tabulated below. The table is based on adverse reactions reported during clinical trials and/or post-marketing use. All ADRs are listed by system organ class and frequency; very common (≥ 1/10), common ( 1/100 to < 1/10), uncommon ( 1/1,000 to < 1/100), rare ( 1/10,000 to < 1/1,000) and not known (cannot be estimated from the available data). Within each frequency grouping, ADRs are presented in order of decreasing seriousness.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-02-25T11:45:00Z · SHA-256 7184cfbc7f9e05ce1e99b04023c799d93f0bd912f125aaadedecf6de2f657133 · Passage 0be3bf34c74bfe99b94728829e011665fca2f679a1e186b19b95f35054c9545c · Zeichen 290–825 im Abschnitt